Allergan Sales recalls
Allergan Sales appears in 14 official U.S. recall notices indexed by RecallRadar, most recently on 2024-05-08.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 14 |
|---|---|
| Published | 2015-09-30 to 2024-05-08 |
| By agency | FDA Drug (13), FDA Device (1) |
| By classification | Class II (11), Class III (3) |
| By status | terminated (13), ongoing (1) |
| Distribution named in notices | TN, US |
Recalls
- Keller Funnel 2, REF: HA-001, STERILEEO, Rx Only
FDA Device · Class II · 2024-05-08 · Allergan Sales
Reason: Their is a potential that breast implants lack the lubricious coating that allows them to slide through the funnels during the implantation procedure. - Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc
FDA Drug · Class II · 2019-04-03 · Allergan Sales
Reason: cGMP Deviations - Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612
FDA Drug · Class III · 2017-11-22 · Allergan Sales
Reason: Failed Impurities/Degradation Specifications. - Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03
FDA Drug · Class III · 2017-11-22 · Allergan Sales
Reason: Failed Impurities/Degradation Specifications. - Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by…
FDA Drug · Class II · 2017-07-05 · Allergan Sales
Reason: Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities. - Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08
FDA Drug · Class III · 2017-04-19 · Allergan Sales
Reason: Failed Impurities/Degradation Specifications - TAZORAC (tazarotene) Gel 0.05%, Rx only, For Dermatologic Use Only, Not for Ophthalmic Use, packaged in a) 30 g tubes (NDC: 0023-8335-03, U…
FDA Drug · Class II · 2016-10-19 · Allergan Sales
Reason: Failed Content Uniformity Specifications - TAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample containers, Manufactured by: Allergan Inc., Irvine, CA…
FDA Drug · Class II · 2016-10-19 · Allergan Sales
Reason: Failed Content Uniformity Specifications - Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612
FDA Drug · Class II · 2016-07-13 · Allergan Sales
Reason: Failed Content Uniformity Specifications. - Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine,…
FDA Drug · Class II · 2016-07-13 · Allergan Sales
Reason: Failed Content Uniformity Specifications. - Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) Net wt. 0.12 oz (3.5 g) tubes (NDC…
FDA Drug · Class II · 2015-09-30 · Allergan Sales
Reason: Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially intr… - BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0.2 %, 3.5 g tube, Rx only, ALLERGAN, Irvine, Cali…
FDA Drug · Class II · 2015-09-30 · Allergan Sales
Reason: Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially intr… - Refresh P.M. (Mineral Oil 42.5% and White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt. 0.12 oz (3.5 g) tube, Allergan, Inc., 2525 Dupo…
FDA Drug · Class II · 2015-09-30 · Allergan Sales
Reason: Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially intr… - FML (fluorometholone ophthalmic ointment) 0.1%, 3.5 g tube, Rx only, Allergan, Inc., Irvine, CA 92612, NDC 0023-0316-04, UPC 3 0023-0316-04…
FDA Drug · Class II · 2015-09-30 · Allergan Sales
Reason: Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially intr…